The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 6, 2001, Pages 1204-1210

  Lin, Feng Ying C ^a   Brenner, Ruth A ^a   Johnson, Yvette R ^a   Azimi, Parvin H ^b   Philips III, Joseph B ^c   Regan, Joan A ^d   Clark, Penny ^e   Weisman, Leonard E ^f   Rhoads, George G ^g   Kong, Fanhui ^h   Clemens, John D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^h WESTAT   (United States)

Author keywords

Early onset disease; Effectiveness; Group B Streptococcus; Intrapartum antibiotic prophylaxis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS AGALACTIAE;

EID: 0035340489     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.113875     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996;45:RR-7:1-24.
2. Philipson EH, Herson V. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: Who should be treated? Am J Perinatol 1996;13:487-90.
3. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983;148:795-801.
4. Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985;35:267-80.
5. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. Washington: The College; 1992. Technical Bulletin No.: 170.
6. SAS Inc. SAS/STAT Software: Exchanges and Enhancements Through Release 6.11. Cary (NC): SAS; 1996.
7. Greenwood M Jr, Yule GU. The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med 1915;8:113-9.
8. Pass MA, Gray BM, Khare S, Dillon HC Jr. Prospective studies of group B streptococcal infections in infants. J Pediatr 1979;95:437-43.
9. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al. Population-based risk factors for neonatal group B streptococcal disease: Results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
10. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease, III: Interruption of mother-to-infant transmission. J Infect Dis 1983;148:810-6.
11. Baker CJ. Antibiotic therapy in neonates whose mothers have received intrapartum group B streptococcal chemoprophylaxis. Pediatr Infect Dis J 1990;9:149-50.
12. Ascher DP, Becker JA, Yoder BA, Weisse M, Waecker NJ, Heroman WM, et al. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis. J Perinatol 1993;13:212-6.
13. De Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B Streptococcus. Obstet Gynecol 1998;91:112-4.
14. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis. Obstet Gynecol 1994;83:483-94.
15. Garland SM, Fliegner JR. Group B streptococci and neonatal infections: The case for intrapartum chemoprophylaxis. Aust N ZJ Obstet Gynaecol 1991;31:119-22.
16. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
17. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73: 583-7.
18. Morales WJ, Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13-6.
19. Factor SH, Levine OS, Nassar A, Potter JN, Fajardo A, O'Sullivan MJ, et al. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol 1998;179:1568-71.